Skip to content
value.today

Piraeus Medical, Inc.

Total raised
$19 M
3 rounds on record
Latest round
$11 M
Mar 2026
First round on record
Jul 2024
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Piraeus Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2026$11 MNo. 3$10 to $50 million

Piraeus Medical, Inc.: Raise no. 3, Mar 2026

Investors in this round

25 investors had bought by the notice of Oct 7, 2026: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $12 M offered; $2 M still to sell
Smallest investment taken
$1,000
What was sold
equity, other: Shares of Issuer Preferred Stock and the shares of capital stock of Issuer into which such shares of Preferred Stock may convert.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jared Hutar · Executive Officer, Director
  • Keith Kallmes · Director
  • Kevin Kallmes · Director
  • Martin Omid Akhavan · Director
  • Ryan Egeland · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jared Hutar, Ceo. Newest notice filed Oct 7, 2026 (1 amendment). Read the notice at the SEC.

equitySEC
Feb 2025$2 MNo. 2$2 to $10 million

Piraeus Medical, Inc.: Raise no. 2, Feb 2025

Investors in this round

65 investors had bought by the notice of Feb 19, 2025: 65 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$500
What was sold
equity, other: Shares of Preferred Stock of Issuer and the shares of capital stock of Issuer into which such shares of Preferred Stock may convert.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jared Hutar · Executive Officer, Director
  • Keith Kallmes · Director
  • Kevin Kallmes · Director
  • Martin Omid Akhavan · Director
  • Ryan Egeland · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jared Hutar, Ceo. Newest notice filed Feb 19, 2025. Read the notice at the SEC.

equitySEC
Jul 2024$6 MNo. 1$2 to $10 million

Piraeus Medical, Inc.: Raise no. 1, Jul 2024

Investors in this round

79 investors had bought by the notice of Jul 23, 2024: 79 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$25,000
What was sold
equity, other: Shares of Preferred Stock of Issuer and the shares of capital stock of Issuer into which such shares of Preferred Stock may convert.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jared Hutar · Executive Officer, Director
  • Keith Kallmes · Director
  • Kevin Kallmes · Director
  • Martin Omid Akhavan · Director
  • Ryan Egeland · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jared Hutar, President and CEO. Newest notice filed Jul 23, 2024. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Piraeus Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2026).

    SEC Form D · Oct 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Oct 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Piraeus Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Piraeus Medical, Inc.
NameRoleNamed in
Jared HutarExecutive officerApr 2026
Ryan EgelandDirectorOct 2026
Jared HutarDirectorApr 2026
Keith KallmesDirectorApr 2026
Kevin KallmesDirectorApr 2026
Martin Omid AkhavanDirectorApr 2026
Ryan Omid EgelandDirectorApr 2026